Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Gray

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Discover Oncology|June 23, 2026
An analysis of succinate dehydrogenase B in pleural mesotheliomaCormac J Jennings, Stefan J Marciniak, Giulia Pinton, et al.
Scientific Reports|January 14, 2018
Induction of protein citrullination and auto-antibodies production in murine exposed to nickel nanomaterialsBashir M Mohamed, Noreen T Boyle, Anja Schinwald, et al.
The Journal of Pathology|December 23, 2011
BRCA1 is an essential mediator of vinorelbine-induced apoptosis in mesotheliomaSara Busacca, Michael Sheaff, Kenneth Arthur, et al.
Scientific Reports|May 8, 2023
Proof of concept nanotechnological approach to in vitro targeting of malignant melanoma for enhanced immune checkpoint inhibitionBandar Alharbi, Husam Qanash, Naif K Binsaleh, et al.
BMC Pulmonary Medicine|August 23, 2022
Altered expression of ACOX2 in non-small cell lung cancerJane S Y Sui, Petra Martin, Anna Keogh, et al.
Cancers|March 28, 2026
An Analysis of G3BP2 in Non-Small Cell Lung CancerLeela S S Bandi, Leah Timon, Elena O'Toole, et al.
Biomedicines|September 28, 2023
An Analysis of JADE2 in Non-Small Cell Lung Cancer (NSCLC)Ciara Murphy, Glòria Gornés Pons, Anna Keogh, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
Liquid Biopsy: A Multi-Parametric Analysis of Mutation Status, Circulating Tumor Cells and Inflammatory Markers in <i>EGFR</i>-Mutated NSCLCMartin P Barr, Anne-Marie Baird, Sophia Halliday, et al.
Oncotarget|October 27, 2017
Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLCLauren MacDonagh, Michael F Gallagher, Brendan Ffrench, et al.
Translational Lung Cancer Research|May 20, 2021
MicroRNA expression profiling and biomarker validation in treatment-naïve and drug resistant non-small cell lung cancerLauren MacDonagh, Michael F Gallagher, Brendan Ffrench, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Discover Oncology|June 23, 2026
An analysis of succinate dehydrogenase B in pleural mesotheliomaCormac J Jennings, Stefan J Marciniak, Giulia Pinton, et al.
Scientific Reports|January 14, 2018
Induction of protein citrullination and auto-antibodies production in murine exposed to nickel nanomaterialsBashir M Mohamed, Noreen T Boyle, Anja Schinwald, et al.
The Journal of Pathology|December 23, 2011
BRCA1 is an essential mediator of vinorelbine-induced apoptosis in mesotheliomaSara Busacca, Michael Sheaff, Kenneth Arthur, et al.
Scientific Reports|May 8, 2023
Proof of concept nanotechnological approach to in vitro targeting of malignant melanoma for enhanced immune checkpoint inhibitionBandar Alharbi, Husam Qanash, Naif K Binsaleh, et al.
BMC Pulmonary Medicine|August 23, 2022
Altered expression of ACOX2 in non-small cell lung cancerJane S Y Sui, Petra Martin, Anna Keogh, et al.
Cancers|March 28, 2026
An Analysis of G3BP2 in Non-Small Cell Lung CancerLeela S S Bandi, Leah Timon, Elena O'Toole, et al.
Biomedicines|September 28, 2023
An Analysis of JADE2 in Non-Small Cell Lung Cancer (NSCLC)Ciara Murphy, Glòria Gornés Pons, Anna Keogh, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
Liquid Biopsy: A Multi-Parametric Analysis of Mutation Status, Circulating Tumor Cells and Inflammatory Markers in <i>EGFR</i>-Mutated NSCLCMartin P Barr, Anne-Marie Baird, Sophia Halliday, et al.
Oncotarget|October 27, 2017
Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLCLauren MacDonagh, Michael F Gallagher, Brendan Ffrench, et al.
Translational Lung Cancer Research|May 20, 2021
MicroRNA expression profiling and biomarker validation in treatment-naïve and drug resistant non-small cell lung cancerLauren MacDonagh, Michael F Gallagher, Brendan Ffrench, et al.
Pageof 11